AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage
Open Access
- 23 March 2006
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 13 (14) , 1097-1103
- https://doi.org/10.1038/sj.gt.3302768
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Eplerenone Shows Renoprotective Effect by Reducing LOX-1–Mediated Adhesion Molecule, PKCε-MAPK-p90RSK, and Rho-Kinase PathwayHypertension, 2005
- Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in Stroke-Prone Spontaneously Hypertensive RatsHypertension, 2004
- Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular RemodelingHypertension, 2003
- Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic HypertensionHypertension, 2003
- Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated RatsCirculation, 2002
- Central imidazoline and angiotensin II receptors in cardiovascular responses to chronic cold exposure in ratsJournal of Thermal Biology, 2001
- Gene Therapy for HypertensionHypertension, 2001
- Cold-Induced Hypertension.Annals of the New York Academy of Sciences, 1997
- Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA ProjectStroke, 1995
- Mineralocorticoid receptors during normal kidney growth and compensatory renal hypertrophyThe Journal of Steroid Biochemistry and Molecular Biology, 1981